Download PDF
Homœopathic Links 2024; 37(01): 045-049
DOI: 10.1055/s-0043-1768647
Case Report

Polycystic Ovarian Syndrome Treated by Homoeopathy: An Evidence-Based Case Report

Laijun Nahar 
1   Regional Research Institute of Homoeopathy, Agartala, under Central Council for Research in Homoeopathy, Ministry of AYUSH, Government of India, Tripura, India
,
Ratan Chandra Shil 
1   Regional Research Institute of Homoeopathy, Agartala, under Central Council for Research in Homoeopathy, Ministry of AYUSH, Government of India, Tripura, India
› Author Affiliations Funding None.
› Further Information
   Permissions and Reprints

Abstract

Background Polycystic ovarian syndrome (PCOS) is one of the most common endocrinopathies among reproductive women. Cardinal manifestations of PCOS include hyperandrogenism, oligo/anovulation and/or polycystic ovarian morphology. Affected women often display notable metabolic co-morbidities. Plenty of evidence on PCOS favouring homoeopathy is available in the literature. In this case, also individualised medicine portrayed a favourable response within a short span of time.

Case Summary A case of PCOS with the complaint of irregular, delayed menses, acne on the face and dark pigmentation on the neck for the last 3 years is presented here. The outcome was assessed by using two validated measurement scales. After 4 months of follow-up, the case was markedly improved on the Outcome Related to Impact on Daily Living (ORIDL) scale (+4) as per the patient's perspective. Clinical improvement was correlated with objective evidence from the ultrasonography report. Modified Naranjo criteria for Homeopathy (MONARCH) score recorded at the final visit (+8 on the ‘−6 to 13’ scale) is suggestive of a high likelihood of improvement by homoeopathic intervention.

Conclusion The case report presented here has produced significant evidence of the effect of individualised homoeopathic medicine in the treatment of PCOS within a short time.

Keywords

polycystic ovarian syndrome - individualised homoeopathic - MONARCH - case report

Patients' Consent

Informed consent has been obtained from the patient.




Publication History

Article published online:
01 February 2024

© 2024. Thieme. All rights reserved.

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Alexandraki KI, Kandaraki EA, Poulia KA, Piperi C, Papadimitriou E, Papaioannou TG. Assessment of early markers of cardiovascular risk in polycystic ovary syndrome. TouchREV Endocrinol 2021; 17 (01) 37-53
    CrossrefPubMedGoogle Scholar
  • 2 Azziz R, Tarlatzis R, Dunaif A. et al; Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81 (01) 19-25
    CrossrefPubMedGoogle Scholar
  • 3 Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab 2017; Feb 1; 102 (02) 604-612
    PubMedGoogle Scholar
  • 4 Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol 2011; 24 (04) 223-227
    CrossrefPubMedGoogle Scholar
  • 5 March WA, Moore VM, Willson KJ, Phillips DIW, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25 (02) 544-551
    CrossrefPubMedGoogle Scholar
  • 6 Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007; 370 (9588): 685-697
    CrossrefPubMedGoogle Scholar
  • 7 Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010; 8: 41
    CrossrefPubMedGoogle Scholar
  • 8 Teede HJ, Joham AE, Paul E. et al. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity (Silver Spring) 2013; 21 (08) 1526-1532
    CrossrefPubMedGoogle Scholar
  • 9 Wang R, Li W, Bordewijk EM. et al; Reproductive Medicine Network+, International Ovulation Induction IPDMA Collaboration. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis. Hum Reprod Update 2019; 25 (06) 717-732
    CrossrefPubMedGoogle Scholar
  • 10 Berger JJ, Bates Jr GW. Optimal management of subfertility in polycystic ovary syndrome. Int J Womens Health 2014; 6 (01) 613-621
    PubMedGoogle Scholar
  • 11 Rath P. Management of PCOS through homoeopathy-a case report. Indian J Res Homoeopath 2018; 12 (02) 95
    CrossrefPubMedGoogle Scholar
  • 12 Lamba C, Oberai P, Manchanda R, Rath P, Bindu H, Padmanabhan M. Evaluation of homoeopathic treatment in polycystic ovary syndrome: a single-blind, randomised, placebo-controlled pilot study. Indian J Res Homoeopath 2018; 12 (01) 35
    CrossrefPubMedGoogle Scholar
  • 13 Hahnemann S. Organon of Medicine. 5th & 6th ed.. New Delhi: B Jain Publishers Pvt Ltd; 2015
    Google Scholar
  • 14 Gupta G, Gupta N, Singh S, Roja V, Dewan D. Homoeopathic treatment of women with polycystic ovarian syndrome: a prospective observational study. Indian J Res Homoeopath 2021; 15 (01) 12-23
    CrossrefPubMedGoogle Scholar
  • 15 van Haselen RA. Homeopathic clinical case reports: Development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline. Complement Ther Med 2016; Apr; 25: 78-85
    CrossrefPubMedGoogle Scholar
  • 16 Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. CARE Group. The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol 2014; 67 (01) 46-51
    CrossrefPubMedGoogle Scholar
  • 17 Shah J. Hompath Classic-Homeopathic Software. Version 8.0 Premium. Mumbai: Hompath; 2005
    PubMedGoogle Scholar
  • 18 Kent JT. Lectures on Homoeopathic Philosophy. New Delhi: B. Jain Publishers (P) Ltd.; 2007
    Google Scholar
  • 19 Roberts HA. The Principles and Art of Cure by Homoeopathy. New Delhi: B. Jain Publishers (P) Ltd.; 2008: 7-285
    Google Scholar
  • 20 Reilly D, Mercer SW, Bikker AP, Harrison T. Outcome related to impact on daily living: preliminary validation of the ORIDL instrument. BMC Health Serv Res 2007; 7: 139
    CrossrefPubMedGoogle Scholar
  • 21 Stub T, Kristoffersen AE, Alræk T, Musial F, Steinsbekk A. Risk in homeopathy: classification of adverse events and homeopathic aggravations–a cross sectional study among Norwegian homeopath patients. Complement Ther Med 2015; 23 (04) 535-543
    CrossrefPubMedGoogle Scholar
  • 22 Stub T, Salamonsen A, Alraek T. Is it possible to distinguish homeopathic aggravation from adverse effects? A qualitative study. Forsch Komplement Med 2012; 19 (01) 13-19
    CrossrefPubMedGoogle Scholar
  • 23 Lamba CD, Gupta VK, van Haselen R. et al. Evaluation of the modified Naranjo criteria for assessing causal attribution of clinical outcome to homeopathic intervention as presented in case reports. Homeopathy 2020; 109 (04) 191-197
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Gupta G. Role of homoeopathic medicines in cases of polycystic ovarian disease assessed by modern diagnostic parameters. 2018; 2: 15-25
    PubMedGoogle Scholar
  • 25 Rath P. A case of infertility due to PCOS treated successfully with homoeopathy. Int J Homoeopath Sci 2020; 4 (02) 249-260
    CrossrefPubMedGoogle Scholar
  • 26 Dabhi DP, Mathur S, Kamboj M. Usefulness of individualised homoeopathic medicines in treatment of polycystic ovarian disease: an evidence based case series. International Journal of Ayush Case Reports 2020; 4 (01) 20-25
    PubMedGoogle Scholar
  • 27 Parveen S, Das S. Homeopathic treatment in patients with polycystic ovarian syndrome: a case series. Homeopathy 2021; 110 (03) 186-193
    PubMedGoogle Scholar
  • 28 Gupta G. Polycystic ovarian disease (PCOD). Homoeopath Herit 2009; 11-17
    PubMedGoogle Scholar